IJR News

Displaced Lebanese Residents Say Israeli Drones Raze Southern Villages — Sep 11, 2026Residents of Mansouri in southern Lebanon, displaced to nearby towns, watch as Israeli drones drop explosives on homes and the village’s public school is demolished, all amid a fragile ceasefire and Israeli control of large parts of the area. They blame both Israel and Lebanese authorities for destroying their livelihoods, highlighting a prolonged occupation while regional diplomacy stalls and civilians remain at risk.

+2

Derek Foss It's heartbreaking to see drones demolishing entire villages like Mansouri even during a ceasefire. The people there deserve accountability from both Israel and their own government.

Myriad Genetics, SOPHiA GENETICS and AstraZeneca advance prostate cancer biomarkerHealth — 2dMyriad Genetics, SOPHiA GENETICS and AstraZeneca are collaborating to advance Myriad’s prostate cancer genomic instability score, designed to identify tumors with features associated with homologous recombination deficiency. Myriad’s MyChoice CDx test will generate the score, while SOPHiA plans to develop a decentralized companion diagnostic; the technology is being studied for clinical trials and is not yet an approved prostate cancer test.

0

AstraZeneca Completes $2B Summit Cancer Drug InvestmentBusiness — Oct 2, 2026AstraZeneca has completed its $2 billion equity investment in Summit Therapeutics to accelerate development of ivonescimab, an investigational PD-1/VEGF cancer antibody. The companies are also advancing clinical collaborations that pair ivonescimab with antibody-drug conjugates across several cancers, including lung and breast cancer.

0

AstraZeneca invests $2 billion in Summit cancer drug partnership — Sep 28, 2026AstraZeneca will invest $2 billion in Summit Therapeutics convertible preferred shares, with Summit stock up more than 17% after-hours ahead of a November 14 FDA decision on ivonescimab.

+1

Marcus Bell This deal could help bring the cancer drug to market faster if the November decision goes well.

Prozorova Disputes Concussion Withdrawal From Singapore Semifinal — Sep 25, 2026Organizers withdrew Tatiana Prozorova from the Singapore Open semifinal under concussion protocol after a doubles smash grazed her cheek; she says she felt fine and disputes the call.

+2

Chris Dalton Prozorova knows her own body best and should have been cleared to play the semifinal if she felt ready after the ball strike.

AP Top 25 College Football TeamsRankingCollege football fans argue endlessly over which programs deserve the top spots in the AP Poll based on wins, schedule strength, and legacy.

Imfinzi Bladder Combo Wins FDA Priority Review — Sep 25, 2026Up to half of muscle-invasive bladder cancer patients cannot take standard chemo. FDA gave Priority Review to AstraZeneca's IMFINZI-enfortumab combo for them; decision due Q4 2026.

+2

Maya Lindstrom Priority review makes sense here but the 2026 decision date still leaves people waiting too long for access.

Legend Biotech names Novartis executive Ingrid Zhang CEO — Sep 15, 2026Legend Biotech appointed Ingrid Zhang as Chief Executive Officer, effective September 15, 2026, with interim CEO Alan Bash becoming President of CARVYKTI. Zhang, a former Novartis executive and China head, brings broad global leadership experience from AstraZeneca, Pfizer, and McKinsey as the board positions Legend for its next growth phase.

+2

Tom Gallagher Hiring someone with McKinsey and AstraZeneca experience signals the board wants tighter global operations going forward.

AstraZeneca Breast Cancer Trial Misses Key Goal — Sep 11, 2026AstraZeneca’s breast cancer pill camizestrant (Etcamah) failed to improve progression-free survival in a late-stage trial when added to standard therapy, despite an earlier ESR1 mutation–targeted approval and after-hours stock weakness. The broader trial that reached more patients failed, while a separate study in ESR1-mutant patients showed a meaningful benefit, underscoring a split outcome for the drug’s potential.

+3

Marcus Bell It's frustrating the overall trial missed but good the ESR1 group still saw real benefit from the drug.

Mystery Deepens: Something Was Supposed to Be Beneath Razed Georgia Guidestones, but Where Is It?Opinion — Jul 25, 2022The Georgia Guidestones: They were a strange, cryptic roadside attraction that some called the “American Stonehenge” and others claimed were satanic. They are no more, thanks to an unknown vandal setting off a bomb at…

0

Red Tape Is Keeping Disaster Survivors In Limbo. Here’s How Trump Can Fix It — Jun 25, 2026Nearly two years after Hurricane Helene tore through western North Carolina, and a year and a half after wildfires razed whole Los Angeles neighborhoods, survivors are still waiting for permission to rebuild. The…

0

Amazon Rainforest Razed To Build Highway For UN Climate Summit — Mar 12, 2025Ahead of the COP30 climate summit in Belém, Brazil, developers are carving a four-lane highway through protected tracts of the Amazon rainforest to ease travel for attendees. The highway, one of several infrastructure…

0

Most Influential Women in World HistoryYourlist — RankingFrom ancient queens who ruled empires to modern activists who changed laws, these women left indelible marks on politics, science, and culture. Vote for who you think shaped history most profoundly.

Protests Erupt in NYC As Deadly Clash Between Marine and Subway Harasser Becomes ‘New George Floyd’ SituationReporting — May 4, 2023The summer of 2020 can be characterized by a massive, ignominious cultural event: the riots that razed businesses and resulted in dozens of deaths across the country in “honor” of George Floyd following his death in…

0

After Tornado Levels Animal Shelter, Rescuers Find a Blind Cat Alive in the Rubble, Give It a Special NameReporting — Mar 25, 2022Animal rescuers were on the scene at the Jacksboro (Texas) Animal Shelter on Tuesday, one day after a tornado ripped through the building. The shelter was razed by an EF3 tornado in Jacksboro, which packed winds of 140…

0

EXCLUSIVE: Legacy Ranchers Fear Solar Industry Razing Farmland Into ‘Dust Bowl’ — Sep 11, 2025The solar industry is bulldozing over legacy farmland in Arizona, leaving the land barren as the sector pursues a so-called green solution to America’s energy crisis, several local ranchers told the Daily Caller News…

0

After Razing Democrats’ Climate Policies, Trump Directs Admin To Unleash ‘Beautiful, Clean’ Coal — Mar 18, 2025President Donald Trump announced Monday evening he is “authorizing” his administration to produce coal power, citing China’s “tremendous economic advantage” over the United States due to the country’s pro-coal policies…

0

Support Trump vs Support DemocratsYourlist — VS BattleEvery executive order, court fight, and agency purge just adds another tally mark to the same permanent scoreboard.

Community Comes Together to Help Couple Rescue Pets Left Behind After Wildfire Took EverythingReporting — Jul 12, 2021Don Glasgow and Tricia Thorpe had found a little piece of paradise in Lytton, Canada. Their farm was home to goats, chickens, alpacas, sheep, cats and dogs — but last week, their home was razed. A fire tore through…

0

Ascelia Completes FDA Meeting on OrviglanceHealth — Sep 8, 2026Biopharma firms report a mix of regulatory progress: Ascelia Pharma advances its Orviglance NDA with an FDA Type A meeting held and minutes due in about 30 days, while AstraZeneca secures FDA approval for Etcamah (camizestrant) after an advisory panel opposed it earlier, signaling a potential shift in benefit-risk assessment. Ascletis Pharma launches a US Phase I trial for ASC36 obesity drug under an IND, highlighting ongoing development in metabolism therapies alongside expectations of further data and pricing implications for investors.

0

Tezspire meets Phase 3 endpoints in eosinophilic esophagitisHealth — Aug 27, 2026AstraZeneca and Amgen's Tezspire met its primary and secondary endpoints in the Phase 3 CROSSING trial for eosinophilic esophagitis, with improvements in histologic remission and reduced dysphagia sustained through week 52. The results bolster Tezspire’s potential as a multi-indication biologic across epithelial-driven inflammatory diseases, building on existing approvals for severe asthma and chronic rhinosinusitis with nasal polyps.

0

AstraZeneca Ends Phase III Lung Cancer Trial — Aug 17, 2026AstraZeneca reports a setback as its Phase III trial of volrustomig plus chemotherapy in PD-L1 negative metastatic non-small cell lung cancer is halted after an independent data review found it unlikely to meet primary endpoints, while another late-stage study in cervical cancer and other indications continues. In a positive contrast, AZN and partners SAFFRON showed that Tagrisso combined with Orpathys significantly improved progression-free and overall survival, underscoring a mixed near-term outlook but ongoing strength in its immuno-oncology pipeline.

0

Nestlé Uses AI to Target GLP-1 UsersHealth — Aug 14, 2026The rapid rise of GLP-1 weight‑loss drugs is reshaping the market as Nestlé leverages AI to turn potential threats into opportunities by developing nutrition products and addressing drug side effects, while major pharma players like Lilly and Novo Nordisk navigate revenue trajectories and competitive disputes. Across the industry, executives see GLP-1 therapies expanding beyond weight loss into broader health benefits, with AstraZeneca highlighting broader applications and regulators flagging safety and counterfeit risks as demand climbs.

0

Columbus officer grazed; suspect in custody, chargedWorld — Aug 8, 2026An East Side Columbus standoff with a male armed with two handguns left a police officer grazed by a bullet and hospitalized, as witnesses reported up to 20 shots fired in a roughly 30-minute confrontation. The suspect was eventually taken into custody after threatening himself with the guns, with no other injuries reported.

0

AstraZeneca Posts Q2 Beat, Reaffirms 2026 Outlook — Jul 24, 2026AstraZeneca beat second-quarter profit expectations and reaffirmed its 2026 outlook despite concerns about future growth after a trial setback, as investors await further details on its earnings trajectory. Analysts are mixed but broadly positive, with several buy ratings and a focus on the upcoming Q2 results and oncology-driven revenue, amid a broader market backdrop of cautious trading ahead of earnings.

0

EU Approves Etcamah in First-Line ER+ Breast Cancer — Jul 23, 2026AstraZeneca’s Etcamah (camizestrant) won EU approval to be used with CDK4/6 inhibitors as a first-line treatment for ER-positive, HER2-negative advanced breast cancer in patients with ESR1 mutations, based on SERENA-6 trial results showing a 56% reduction in progression or death. The drug already has approvals in Japan, the UAE, and Saudi Arabia, with U.S. review ongoing and the EU decision highlighting its potential to expand AstraZeneca’s oncology footprint as it targets endocrine-resistant disease.

0

Portland Man Arrested After Knife Attack on OfficersWorld — Jul 21, 2026A 33-year-old man, Stephen T. Scazzafavo, was arrested after assaulting a work crew, throwing a knife at Portland police officers, and threatening officers with a metal hiking stick and a stun-gun flashlight near Northeast Brazee Street and Northeast 122nd Avenue. He damaged a patrol vehicle windshield, caused thousands of dollars in damage to the crew’s vehicle, sustained one minor officer injury, and faces multiple charges including criminal mischief, harassment, multiple assaults, and weapons offenses.

0